$13.93
0.12 (-0.85%)
Last updated: May 31, 2026 06:44
Fundamentals Overview
InMode Ltd. is in the middle of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+140.5% upside vs price
Profitability
Risk (Beta)
1.98 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +140.5% upside vs price · Analyst grade: A+ · 3M vs Healthcare sector: +5.1%
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -9.4% · Beta 1.98 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A+. Recent institutional grades: majority downgrades. Current institutional positions: Hold: 14, Neutral: 5, Overweight: 11.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $33.49; current price is $13.93. That’s a +140.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 10.22 |
| DCF value (model) | $33.49 (140.5% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.34 |
| P/S (TTM) | 2.36 |
| P/FCF (TTM) | 9.74 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 8.8 |
| Quick Ratio (TTM) | 7.88 |
| Cash Ratio (TTM) | 5.1 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 23.27% |
| Gross margin (TTM) | 77.84% |
| Operating margin (TTM) | 21.31% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for INMD.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Baird | maintain | Neutral | Neutral | 2026-05-07 |
| Barclays | maintain | Overweight | Overweight | 2026-05-07 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-12-17 |
| UBS | maintain | Neutral | Neutral | 2025-11-06 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-10-10 |
| Needham | maintain | Hold | Hold | 2025-10-10 |
| Needham | maintain | Hold | Hold | 2025-07-30 |
| Barclays | maintain | Overweight | Overweight | 2025-07-30 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-07-11 |
| Barclays | maintain | Overweight | Overweight | 2025-04-30 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-04-29 |
| UBS | maintain | Neutral | Neutral | 2025-04-29 |
| BTIG | downgrade | Buy | Neutral | 2025-04-29 |
| Needham | maintain | Hold | Hold | 2025-04-28 |
| Jefferies | maintain | Hold | Hold | 2025-04-14 |
| Needham | maintain | Hold | Hold | 2025-04-14 |
| Needham | maintain | Hold | Hold | 2025-04-09 |
| Barclays | maintain | Overweight | Overweight | 2025-02-05 |
| Needham | maintain | Hold | Hold | 2025-02-04 |
| Barclays | maintain | Overweight | Overweight | 2025-01-09 |
| Barclays | maintain | Overweight | Overweight | 2024-10-14 |
| Jefferies | downgrade | Buy | Hold | 2024-07-23 |
| Barclays | maintain | Overweight | Overweight | 2024-07-15 |
| Canaccord Genuity | maintain | Hold | Hold | 2024-07-12 |
| Barclays | maintain | Overweight | Overweight | 2024-04-12 |
| Barclays | maintain | Overweight | Overweight | 2024-02-15 |
| UBS | maintain | Neutral | Neutral | 2024-02-14 |
| Barclays | maintain | Overweight | Overweight | 2024-01-18 |
| Barclays | maintain | Overweight | Overweight | 2024-01-04 |
| Canaccord Genuity | maintain | Hold | Hold | 2023-12-07 |